About Arialys
Arialys is a company based in La Jolla (United States) founded in 2021.. Arialys has raised $72.8 million across 2 funding rounds from investors including ARE, Avalon Bio Ventures and Catalys Pacific. Arialys offers products and services including ART5803. Arialys operates in a competitive market with competitors including George Institute, The Fertility Partners, HD, Novus Diagnostics and Genertec Universal Medical Group, among others.
- Headquarter La Jolla, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$72.8 M (USD)
in 2 rounds
-
Latest Funding Round
$14.8 M (USD), Seed
Jun 13, 2025
-
Investors
ARE
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Arialys
Arialys offers a comprehensive portfolio of products and services, including ART5803. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Antibody that blocks autoantibodies to treat anti-NMDA receptor encephalitis.
Funding Insights of Arialys
Arialys has successfully raised a total of $72.8M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $14.8 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $14.8M
-
First Round
First Round
(12 Sep 2023)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2025 | Amount | Seed - Arialys | Valuation |
investors |
|
| Sep, 2023 | Amount | Seed - Arialys | Valuation | Avalon Bio Ventures , Catalys Pacific |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Arialys
Arialys has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Avalon Bio Ventures and Catalys Pacific. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
Invests in biotech companies via global networks and partnerships for disease treatments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Arialys
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Arialys
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Arialys Comparisons
Competitors of Arialys
Arialys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as George Institute, The Fertility Partners, HD, Novus Diagnostics and Genertec Universal Medical Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical research is conducted by the institute in health fields.
|
|
| domain | founded_year | HQ Location |
Business consulting services for fertility practices are provided.
|
|
| domain | founded_year | HQ Location |
Medical information services are provided in the healthcare sector.
|
|
| domain | founded_year | HQ Location |
Provider of diagnostic information services for clinicians
|
|
| domain | founded_year | HQ Location |
Provider of medical information solutions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Arialys
When was Arialys founded?
Arialys was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is Arialys located?
Arialys is headquartered in La Jolla, United States. It is registered at La Jolla, California, United States.
Who is the current CEO of Arialys?
Peter Flynn is the current CEO of Arialys.
Is Arialys a funded company?
Arialys is a funded company, having raised a total of $72.8M across 2 funding rounds to date. The company's 1st funding round was a Seed of $58M, raised on Sep 12, 2023.
What does Arialys do?
Arialys was established in 2021 in La Jolla, United States, as a private biotech company. Focus is placed on the development of precision medicines targeting autoimmune neuropsychiatric diseases. Scientific advancements in this sector are investigated to support therapeutic interventions for individuals impacted by these conditions. Operations center on research and innovation within the biotechnology field.
Who are the top competitors of Arialys?
Arialys's top competitors include George Institute, The Fertility Partners and HD.
What products or services does Arialys offer?
Arialys offers ART5803.
Who are Arialys's investors?
Arialys has 5 investors. Key investors include ARE, Avalon Bio Ventures, Catalys Pacific, Turmeric Acquisition Corp, and Johnson & Johnson Innovation – JJDC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.